Official UK visa sponsor profile for Stablepharma Limited in Bath, including current register status, route details, and public company data.
Stablepharma Limited is a manufacturing company specializing in the conversion of existing vaccines and biological products into thermostable formulations, reducing waste throughout their lifecycle. Established in Bristol, UK in 2012 under Reg: 07925414, Stablepharma was awarded an EIC Accelerator Grant totaling €2.5m to develop its innovative technology platform – StablevaX™. The core of the company’s operation is the conversion process which utilizes advanced scientific techniques to transform vulnerable vaccines and biological materials into products suitable for long-term storage without refrigeration. This addresses a critical challenge in global health: ensuring vaccine integrity during transport and distribution, mitigating significant wastage rates that hinder effective immunization programs worldwide. Stablepharma operates with international presence currently lacking, focusing primarily on the European market. The company employs a team of skilled workers and is rated as a Worker (A rating) within its organization. The StablevaX™ platform represents a significant technological advancement designed to minimize losses associated with vaccine degradation during handling and transportation.
Official UK visa sponsor profile for Stablepharma Limited in Bath, including current register status, route details, and public company data.
Stablepharma Limited is a manufacturing company specializing in the conversion of existing vaccines and biological products into thermostable formulations, reducing waste throughout their lifecycle. Established in Bristol, UK in 2012 under Reg: 07925414, Stablepharma was awarded an EIC Accelerator Grant totaling €2.5m to develop its innovative technology platform – StablevaX™. The core of the company’s operation is the conversion process which utilizes advanced scientific techniques to transform vulnerable vaccines and biological materials into products suitable for long-term storage without refrigeration. This addresses a critical challenge in global health: ensuring vaccine integrity during transport and distribution, mitigating significant wastage rates that hinder effective immunization programs worldwide. Stablepharma operates with international presence currently lacking, focusing primarily on the European market. The company employs a team of skilled workers and is rated as a Worker (A rating) within its organization. The StablevaX™ platform represents a significant technological advancement designed to minimize losses associated with vaccine degradation during handling and transportation.
Yes, Stablepharma Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Stablepharma Limited is classified under: Manufacture of basic pharmaceutical products.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Stablepharma Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Stablepharma Limited is classified under: Manufacture of basic pharmaceutical products.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.